Circular RNA circ_0008274 upregulates granulin to promote the progression of hepatocellular carcinoma via sponging microRNA -140-3p

References

• Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017 Mar;34(2):153–159.
   PubMed Web of Science ®Google Scholar
• Dhir M, Melin AA, Douaiher J, et al. Update of treatment options and controversies in the management of hepatocellular carcinoma. Ann Surg. 2016 Jun;263(6):1112–1125.
   PubMed Web of Science ®Google Scholar
• Yao JT, Zhao SH, Liu QP, et al. Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value. Pathol Res Pract. 2017 May;213(5):453–456.
   PubMed Web of Science ®Google Scholar
• Bruix J, Reig M, Evidence-Based Diagnosis SM. Staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016 Apr;150(4):835–853.
   PubMed Web of Science ®Google Scholar
• Qu S, Liu Z, Yang X, et al. The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 2018 Feb;1(414):301–309.
   Google Scholar
• Yu J, Yang M, Zhou B, et al. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway. Clin Sci (Lond). 2019 Jul 15;133(13):1487–1503.
   PubMed Web of Science ®Google Scholar
• Li Q, Pan X, Zhu D, et al. RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p/PKM2 axis under hypoxic stress. Hepatology. 2019 Oct;70(4):1298–1316.
   PubMed Web of Science ®Google Scholar
• Zhou GK, Zhang GY, Yuan ZN, et al. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2018 Dec;22(24):8772–8780.
   PubMed Web of Science ®Google Scholar
• Ito S, Hirabayashi K, Moriishi K, et al. Novel sex-dependent differentially methylated regions are demethylated in adult male mouse livers. Biochem Biophys Res Commun. 2015 Jul 10;462(4):332–338.
   PubMed Web of Science ®Google Scholar
• Chen L, Heikkinen L, Wang C, et al. Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 2019 Sep 27;20(5):1836–1852.
   PubMed Web of Science ®Google Scholar
• Debnath T, Deb Nath NC, Kim EK, et al. Role of phytochemicals in the modulation of miRNA expression in cancer. Food Funct. 2017 Oct 18;8(10):3432–3442.
   PubMed Web of Science ®Google Scholar
• Zhang Q-Y, Men C-J, Ding X-W. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN. J Cell Biochem. 2019 Sep;120(9):14885–14898.
   PubMed Web of Science ®Google Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388.
   PubMed Web of Science ®Google Scholar
• Chang P, Wang F, Li Y. Hsa_circ_0000673 is down-regulated in gastric cancer and inhibits the proliferation and invasion of tumor cells by targetting miR-532-5p. Biosci Rep. 2018 Sep 19;38(5):BSR20180538.
   PubMedGoogle Scholar
• Yao Z, Luo J, Hu K, et al. ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways. Mol Oncol. 2017 Apr;11(4):422–437.
   PubMed Web of Science ®Google Scholar
• Li R, Jiang J, Shi H, et al. CircRNA: a rising star in gastric cancer. Cell Mol Life Sci. 2020 May;77(9):1661–1680.
   PubMed Web of Science ®Google Scholar
• Wang L, Long H, Zheng Q, et al. RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol Cancer. 2019 Jul 19;18(1):119.
   PubMed Web of Science ®Google Scholar
• Huang XY, Huang ZL, Zhang PB, et al. CircRNA-100338 is associated with mTOR signaling pathway and poor prognosis in hepatocellular carcinoma. Front Oncol. 2019 May 14;9:392.
   PubMed Web of Science ®Google Scholar
• Kong Q, Fan Q, Ma X, et al. CircRNA circUGGT2 contributes to hepatocellular carcinoma development via regulation of the miR-526b-5p/RAB1A axis. Cancer Manag Res. 2020 Oct 15;12:10229–10241. PMID: 33116877; PMCID: PMC7571581.
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang F, Sun P. miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis. Bioorg Med Chem. 2020 Feb 1;28(3):115283.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Y, Wang L, et al. miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP. Biomed Pharmacother. 2018 Nov;107:424–432.
   PubMed Web of Science ®Google Scholar
• Salem O, Erdem N, Jung J, et al. The highly expressed 5ʹisomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration. BMC Genomics. 2016 Aug 8;17:566.
   PubMed Web of Science ®Google Scholar
• Dong W, Yao C, Teng X, et al. MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer. Tumour Biol. 2016 Mar;37(3):2973–2985.
   PubMedGoogle Scholar
• Li J, Zhao J, Wang H, et al. MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor. Onco Targets Ther. 2018 Sep 17;11:5885–5894.
   PubMed Web of Science ®Google Scholar
• Lasda E, Circular PR. RNAs: diversity of form and function. RNA. 2014 Dec;20(12):1829–1842.
   PubMed Web of Science ®Google Scholar
• Chen X, Jiang J, Zhao Y, et al. RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p. J Exp Clin Cancer Res. 2020 Jul 11;39(1):133.
   PubMed Web of Science ®Google Scholar
• Wang WX, Wilfred BR, Madathil SK, et al. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol. 2010 Jul;177(1):334–345.
   PubMed Web of Science ®Google Scholar
• Ong CH, Progranulin BA. (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis. Histol Histopathol. 2003 Oct;18(4):1275–1288.
   PubMed Web of Science ®Google Scholar
• Jl W, Fu W, Yj D, et al. Progranulin derivative Atsttrin protects against early osteoarthritis in mouse and rat models. Arthritis Res Ther. 2017 Dec 19;19(1):280.
   PubMedGoogle Scholar
• Vachher M, Arora K, Burman A, et al. GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas. J Cell Biochem. 2020 Apr;121(4):3010–3023.
   PubMed Web of Science ®Google Scholar
• Demorrow S. Progranulin: a novel regulator of gastrointestinal cancer progression. Transl Gastrointest Cancer. 2013 Jul;2(3):145–151.
   PubMedGoogle Scholar
• Ho JC, Ip YC, Cheung ST, et al. Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology. 2008 May;47(5):1524–1532.
   PubMed Web of Science ®Google Scholar